Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.

Literature DB >> 28856577

²²³Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.

Giuseppe De Vincentis¹, Giulia Anna Follacchio¹, Viviana Frantellizzi^2,3, Arsela Prelaj¹, Alessio Farcomeni⁴, Angelo Giuli¹, Vincenzo Bianco¹, Silverio Tomao¹.

Abstract

Entities: Chemical Disease Species

Keywords: 223Ra-dichloride; Bone metastases; CRPC; Elderly; Geriatric assessment

Year: 2017 PMID： 28856577 DOI： 10.1007/s40520-017-0826-4

Source DB: PubMed Journal: Aging Clin Exp Res ISSN： 1594-0667 Impact factor: 3.636

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.

Authors: Viviana Frantellizzi; Fabio Monari; Manlio Mascia; Renato Costa; Giuseppe Rubini; Angela Spanu; Alessio Farcomeni; Elisa Lodi Rizzini; Luca Cindolo; Alessandra Murabito; Valentina Lavelli; Susanna Nuvoli; Laura Cosma; Valeria Dionisi; Anna Giulia Nappi; Marco Andreola; Giuseppe De Vincentis
Journal: Aging Clin Exp Res Date: 2020-05-01 Impact factor: 3.636

2. [Management of mCRPC patients treated with ²²³Radium-dicloride in the scenario of the COVID-19 outbreak].

Authors: V Frantellizzi; G De Vincentis
Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Date: 2020-05-16

3. Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment.

Authors: Viviana Frantellizzi; Arianna Pani; Maria Dea Ippoliti; Alessio Farcomeni; Irvin Aloise; Mirco Colosi; Claudia Polito; Roberto Pani; Giuseppe De Vincentis
Journal: Radiol Oncol Date: 2019-12-19 Impact factor: 2.991

4. Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration.

Authors: Viviana Frantellizzi; Mariano Pontico; Arianna Pani; Roberto Pani; Giuseppe De Vincentis
Journal: Curr Radiopharm Date: 2020

5. Feasibility of a novel photoproduction of ²²⁵Ac and ²²⁷Th with natural thorium target.

Authors: Kwangho Ju; Yonghee Kim
Journal: Sci Rep Date: 2022-01-10 Impact factor: 4.379

Review 6. Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors: Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal: Diagnostics (Basel) Date: 2022-07-21

7. Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with ²²³Radium-dichloride: a national multicenter study.

Authors: Viviana Frantellizzi; Fabio Monari; Manlio Mascia; Renato Costa; Giuseppe Rubini; Angela Spanu; Arianna Di Rocco; Elisa Lodi Rizzini; Luca Cindolo; Maria Licari; Valentina Lavelli; Susanna Nuvoli; Cristina De Angelis; Valeria Dionisi; Cristina Ferrari; Giuseppe De Vincentis
Journal: Ann Nucl Med Date: 2020-07-11 Impact factor: 2.668

7 in total

223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.